Quarterly Report — Form 10-Q — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents
Document/Exhibit Description Pages Size
1: 10-Q Guided Therapeutics, Inc. HTML 498K
2: EX-31 Rule 13A-14(A) / 15(D)-14(A) Certification HTML 22K
3: EX-32 Section 1350 Certification HTML 17K
12: R1 Document and Entity Information HTML 49K
39: R2 Condensed Consolidated Balance Sheets (Unaudited) HTML 129K
46: R3 Condensed Consolidated Balance Sheets (Unaudited) HTML 56K
(Parenthetical)
26: R4 Condensed Consolidated Statements of Operations HTML 89K
(Unaudited)
11: R5 Condensed Consolidated Statements of Cash Flows HTML 101K
(Unaudited)
38: R6 1. Organization, Background, and Basis of HTML 28K
Presentation
45: R7 2. Significant Accounting Policies HTML 71K
27: R8 3. Fair Value of Financial Instruments HTML 44K
10: R9 4. Stockholders' Deficit HTML 87K
17: R10 5. Stock Options HTML 20K
32: R11 6. Litigation and Claims HTML 19K
49: R12 7. Commitments and Contingencies HTML 33K
41: R13 8. Notes Payable HTML 59K
16: R14 9. Short-Term Convertible Debt HTML 40K
31: R15 10. Convertible Debt in Default HTML 63K
47: R16 11. Income (Loss) Per Common Share HTML 26K
40: R17 12. Subsequent Events HTML 37K
18: R18 2. Significant Accounting Policies (Policies) HTML 136K
30: R19 2. Significant Accounting Policies (Tables) HTML 48K
55: R20 3. Fair Value of Financial Instruments (Tables) HTML 41K
34: R21 4. Stockholders' Deficit (Tables) HTML 64K
20: R22 7. Commitments and Contingencies (Tables) HTML 21K
24: R23 8. Notes Payable (Tables) HTML 43K
54: R24 9. Short-Term Convertible Debt (Tables) HTML 22K
33: R25 10. Convertible Debt in Default (Tables) HTML 21K
19: R26 11. Income (Loss) Per Common Share (Tables) HTML 25K
23: R27 1. Organization, Background, and Basis of HTML 36K
Presentation (Details Narrative)
53: R28 2. Significant Accounting Policies (Details) HTML 30K
35: R29 2. Significant Accounting Policies (Details 1) HTML 31K
43: R30 2. Significant Accounting Policies (Details 2) HTML 42K
50: R31 2. Significant Accounting Policies (Details 3) HTML 34K
28: R32 2. Significant Accounting Policies (Details HTML 30K
Narrative)
13: R33 3. Fair Value of Financial Instruments (Details) HTML 35K
44: R34 3. Fair Value of Financial Instruments (Details 1) HTML 31K
51: R35 4. Stockholders' Deficit (Details) HTML 22K
29: R36 4. Stockholders' Deficit (Details 1) HTML 26K
14: R37 4. Stockholders' Deficit (Details 2) HTML 118K
42: R38 7. Commitments and Contingencies (Details) HTML 30K
52: R39 8. Notes Payable (Details) HTML 52K
36: R40 8. Notes Payable (Details 1) HTML 37K
56: R41 8. Notes Payable (Details 2) HTML 39K
25: R42 9. Short-Term Convertible Debt (Details) HTML 32K
21: R43 10. Convertible Debt in Default (Details) HTML 26K
37: R44 11. Income (Loss) Per Common Share (Details) HTML 46K
48: XML IDEA XML File -- Filing Summary XML 99K
22: EXCEL IDEA Workbook of Financial Reports XLSX 79K
4: EX-101.INS XBRL Instance -- gthp-20190930 XML 1.30M
6: EX-101.CAL XBRL Calculations -- gthp-20190930_cal XML 152K
7: EX-101.DEF XBRL Definitions -- gthp-20190930_def XML 342K
8: EX-101.LAB XBRL Labels -- gthp-20190930_lab XML 642K
9: EX-101.PRE XBRL Presentations -- gthp-20190930_pre XML 529K
5: EX-101.SCH XBRL Schema -- gthp-20190930 XSD 136K
15: ZIP XBRL Zipped Folder -- 0001121781-20-000018-xbrl Zip 115K
‘EXCEL’ — IDEA Workbook of Financial Reports
This is an IDEA Workbook.
↑Top
Filing Submission 0001121781-20-000018 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help —
Fri., May 10, 2:39:46.2pm ET